ArticleOncotarget2019

Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer.

Jonathan P Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.